Industry | 2009.10.15
Commonwealth Biotechnologies, Inc. Acquisition of GL Biochem: Market Update
RICHMOND, Va.--(BUSINESS WIRE)--Commonwealth Biotechnologies, Inc. (“CBI”) (NASDAQ Capital Market: CBTE) has recently announced a definitive share purchase agreement to acquire Shanghai-based GL Biochem and associated businesses (the “GL Group”), the largest global supplier of research-grade peptide products and peptide reagents. Management is pleased to provide a market update regarding the history, operations and strategy of the GL Group, the industry and marketplace fo
For more information, please visit
http://www.businesswire.com/news/home/20091014005924/en
